PSTV (STOCKS)
PLUS THERAPEUTICS, Inc. Common Stock
$4.950000
-0.060000 (-1.20%)
Prev close: $5.010000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marc H. Hedrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $33.73M
- Employees
- 21
- P/E (TTM)
- -1.48
- P/B (TTM)
- 2.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-1.05 | $-0.90 | -0.1524 | -16.98% |
|
Dec 2025 (Q4)
|
$-1.04 | $-0.83 | -0.2085 | -25.15% |
|
Sep 2025 (Q3)
|
$-1.00 | $-0.51 | -0.4900 | -96.08% |
|
Jun 2025 (Q2)
|
$0.50 | $-2.30 | +2.7950 | +121.79% |
Financial Statements
| Revenues | $5.18M |
| Benefits Costs and Expenses | $27.60M |
| Costs And Expenses | $31.15M |
| Nonoperating Income/Loss | $6.95M |
| Operating Expenses | $24.06M |
| Research and Development | $9.49M |
| Other Operating Expenses | $14.58M |
| Operating Income/Loss | -$18.88M |
| Income/Loss From Continuing Operations After Tax | -$11.93M |
| Income/Loss From Continuing Operations Before Tax | -$18.66M |
| Net Income/Loss | -$11.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$15.89M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.07 |
| Diluted Earnings Per Share | -$1.10 |
| Basic Average Shares | 182,423,086 |
| Diluted Average Shares | 343,189,218 |
| Assets | $19.92M |
| Current Assets | $18.03M |
| Noncurrent Assets | $1.89M |
| Fixed Assets | $1.01M |
| Other Non-current Assets | $875.00K |
| Liabilities | $7.96M |
| Current Liabilities | $7.96M |
| Noncurrent Liabilities | $0.00 |
| Equity | $11.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.96M |
| Liabilities And Equity | $19.92M |
| Net Cash Flow From Operating Activities | -$20.84M |
| Net Cash Flow From Operating Activities, Continuing | -$20.84M |
| Net Cash Flow From Investing Activities | -$12.95M |
| Net Cash Flow From Investing Activities, Continuing | -$12.95M |
| Net Cash Flow From Financing Activities | $26.94M |
| Net Cash Flow From Financing Activities, Continuing | $26.94M |
| Net Cash Flow | -$6.85M |
| Net Cash Flow, Continuing | -$6.85M |
| Comprehensive Income/Loss | -$11.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.93M |
| Other Comprehensive Income/Loss | $0.00 |